Skip to main content

Medicinal metabolites with common biosynthetic pathways in Solanum nigrum


Solanum nigrum is a medicinal plant belonging to the Solanaceae family. It possesses various therapeutic properties such as anticancer, antioxidant, hepatoprotective, antiulcer, antiinflammatory, antihyperlipidemic, antidiabetic, antibacterial, and antiseizure properties. Numerous secondary metabolites have been isolated from S. nigrum, including (+) syringaresinol (II), (+)-medioresinol (III), scopoletin (IV), tetracosanoic acid (V), and beta-sitosterol (IV). They also contain a variety of toxic secondary metabolites such as alpha-Solanine and alpha-Chaconine, which are steroidal glycoalkaloids. Here, we showed the potential of CRISPR/Cas9 technology to improve and enhance the plant architecture, secondary metabolites, and therapeutic applications in eliminating toxic compounds, especially solanine and chaconine, in S. nigrum.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2


Download references


This paper was supported by Wonkwang University research fund.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Soon Ju Park.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Jabamalairaj, A., Priatama, R.A., Heo, J. et al. Medicinal metabolites with common biosynthetic pathways in Solanum nigrum. Plant Biotechnol Rep 13, 315–327 (2019).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • Solanum nigrum
  • Secondary metabolites
  • Therapeutic properties
  • Medicinal plants
  • Molecular breeding